Sep 24, 2010
Sep 20, 2010
Sep 16, 2010
Sep 14, 2010
Aug 25, 2010
Aug 20, 2010
Aug 13, 2010
(CIDRAP News) The National Institute of Allergy and Infectious Diseases (NIAID) has launched a clinical trial of a dengue virus vaccine, a product that eventually may help prevent a disease to which 2.5 billion people are exposed.
The launching of a trial at the Johns Hopkins Bloomberg School of Public in Baltimore and the University of Vermont in Burlington follows more than a decade of development, the NIAID said in a press release.
Editor's Note: The original news scan on pandemic and Bioshield funding erroneously stated that such funding had been cut from the appropriations bill. This is not the case, and we apologize for the error. The text was corrected Jul 29.
Jul 28, 2010
